GSK-3117391

CAS No. 1018673-42-1

GSK-3117391 ( CHR-5154;GSK3117391;CHR5154 )

Catalog No. M10089 CAS No. 1018673-42-1

GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 177 Get Quote
10MG 295 Get Quote
25MG 502 Get Quote
50MG 709 Get Quote
100MG 1008 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK-3117391
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
  • Description
    GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor, has the potential to complement existing therapies in the treatment of chronic inflammatory disorders such as rheumatoid arthritis.Rheumatoid Arthritis Phase 2 Clinical
  • Synonyms
    CHR-5154;GSK3117391;CHR5154
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    Inflammation/Immunology
  • Indication
    Rheumatoid Arthritis

Chemical Information

  • CAS Number
    1018673-42-1
  • Formula Weight
    389.50
  • Molecular Formula
    C21H31N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OC1CCCC1)[C@H](C2CCCCC2)NCC3=CC=C(CCC(NO)=O)N=C3
  • Chemical Name
    cyclopentyl (S)-2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)amino)acetate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • EDO-S101

    EDO-S101 (Tinostamustine)is a fusion molecule comprising of the alkylator bendamustine and the HDAC-inhibitor vorinostat.

  • Tucidinostat

    Tucidinostat (Chidamide, HBI-8000, CS055) is a novel histone deacetylase (HDAC) inhibitor.

  • Liquiritin apioside

    Liquiritin Apioside is one of the main active components in Suan-Zao-Ren decoction as a treatment for insomnia.